Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
5,045,531
-
Total 13F shares
-
11,591,136
-
Share change
-
+11,589,973
-
Total reported value
-
$4,868,277
-
Price per share
-
$0.42
-
Number of holders
-
6
-
Value change
-
+$4,867,788
-
Number of buys
-
5
-
Number of sells
-
1
Institutional Holders of Allovir, Inc. - Common Stock (ALVR) as of Q4 2024
As of 31 Dec 2024,
Allovir, Inc. - Common Stock (ALVR) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,591,136 shares.
The largest 6 holders included
Octagon Capital Advisors LP, MARSHALL WACE, LLP, TUDOR INVESTMENT CORP ET AL, Parallel Advisors, LLC, EverSource Wealth Advisors, LLC, and SBI Securities Co., Ltd..
This page lists
6
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.